STRO vs VICI
Sutro Biopharma (STRO) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
STRO currently screens at market cap $470.8M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the STRO and VICI stock pages for the full models.
Not investment advice.